Publisher Correction: PAK4 inhibition improves PD-1 blockade immunotherapy.

Gabriel Abril-Rodríguez ,Antoni Ribas,Cristina Puig-Saus,Davis Y Torrejon,Egmidio Medina,William Senapedis,Jennifer Tsoi,Erkan Baloglu,Theodore S Nowicki,Wei Liu,Jesse M Zaretsky,Ignacio Baselga-Carretero,Beata Berent-Maoz,Anusha Kalbasi,Catherine S Grasso,Gardenia Cheung-Lau,Michael J Quist,Alejandro J Garcia,Siwen Hu‐Lieskovan ,Begoña Comı́n-Anduix ,Cun‐Yu Wang

doi:10.1038/s43018-020-0025-7

Publisher Correction: PAK4 inhibition improves PD-1 blockade immunotherapy.

Gabriel Abril-Rodríguez , Antoni Ribas + Show 19 more

Open Access

https://doi.org/10.1038/s43018-020-0025-7

Copy DOI

Journal: Nature Cancer	Publication Date: Jan 22, 2020
Citations: 2

Affiliation: University of California, Los Angeles, Parker Institute for Cancer Immunotherapy, University of Colorado Cancer Center, University of Colorado Denver, Karyopharm Therapeutics (United States), Samueli Institute

#PD-1 Blockade Immunotherapy #PAK4 Inhibition + Show 1 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Author(s): Abril-Rodriguez, Gabriel; Torrejon, Davis Y; Liu, Wei; Zaretsky, Jesse M; Nowicki, Theodore S; Tsoi, Jennifer; Puig-Saus, Cristina; Baselga-Carretero, Ignacio; Medina, Egmidio; Quist, Michael J; Garcia, Alejandro J; Senapedis, William; Baloglu, Erkan; Kalbasi, Anusha; Cheung-Lau, Gardenia; Berent-Maoz, Beata; Comin-Anduix, Begona; Hu-Lieskovan, Siwen; Wang, Cun-Yu; Grasso, Catherine S; Ribas, Antoni

Full Text